New research published in Aging Cell provides insights into how exercise may help to prevent or slow cognitive decline during aging.
May 15, 2024
0
4
Every year roughly 1,000 Canadians are diagnosed with amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig's disease). Some 4,000 Canadians are currently living with the disease.
May 14, 2024
0
0
More than 20,000 volunteers have been recruited to a resource aimed at speeding up the development of much-needed dementia drugs. The cohort will enable scientists in universities and industry to involve healthy individuals ...
May 14, 2024
0
24
Research conducted by the Centenary Institute has revealed a promising new approach to tackling melanoma, an aggressive form of skin cancer notorious for its resistance to conventional treatments.
May 13, 2024
0
0
A new study, led by Jesmond Dalli, professor of molecular pharmacology at Queen Mary University of London, has found that people with a genetic mutation that leads to a reduction in a protein called LGR6, found on the surface ...
May 9, 2024
0
0
Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have pinpointed a combination immunotherapy treatment that enhances the immune response for people with malignant gliomas, an aggressive type of brain tumor ...
May 9, 2024
0
41
An international study led by Dr. Li Qi-Jing from the Agency for Science, Technology and Research (A*STAR) has revealed a mechanism by which melanoma, the most aggressive form of skin cancer, evades the immune system.
May 9, 2024
0
8
A new drug could prevent sepsis-related organ failure and death by restoring the health of a patient's blood vessels. Researchers from The University of Queensland and the Queensland Children's Hospital (QCH) have successfully ...
May 9, 2024
0
12
Researchers at MIT, Brigham and Women's Hospital, and Harvard Medical School have developed a potential new treatment for alopecia areata, an autoimmune disorder that causes hair loss and affects people of all ages, including ...
May 9, 2024
0
153
Researchers at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC) have shown that a breakthrough therapy for treating blood cancers can be adapted to treat solid tumors—an advance ...
May 8, 2024
0
11
